Paper113803
Zimelidine: a therapeutic and pharmacokinetic study in depression.
Coppen A and 3 others. Psychopharmacology (Berl), 1979. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Zimelidine: a therapeutic and pharmacokinetic study in depression. Papers, record 113803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/113803
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Depression | Major topic |
| Pyridines | Major topic |
| Allylamine | |
| Amitriptyline | |
| Body Weight | |
| Bridged Bicyclo Compounds | |
| Double-Blind Method | |
| Evaluation Studies as Topic | |
| Female | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Psychiatric Status Rating Scales |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 834,363 | Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues. | Neuropharmacology | 1977 | https://conductscience.org/library/papers/834363 | PubMed |
| 2 | 341,907 | Effect of zimelidine (H 102/09) in depressive patients. | Arzneimittelforschung | 1977 | https://conductscience.org/library/papers/341907 | PubMed |
| 3 | 321,228 | Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patients. | Eur J Pharmacol | 1977 | https://conductscience.org/library/papers/321228 | PubMed |
| 4 | 14,257,398 | CLINICAL TRIAL OF THE TREATMENT OF DEPRESSIVE ILLNESS. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS CLINICAL PSYCHIATRY COMMITTEE. | Br Med J | 1965 | https://conductscience.org/library/papers/14257398 | PubMed |
| 5 | 947,293 | (Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake. | Acta Pharmacol Toxicol (Copenh) | 1976 | https://conductscience.org/library/papers/947293 | PubMed |
| 6 | 837,638 | Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/837638 | PubMed |
| 7 | 74,566 | Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. | Lancet | 1978 | https://conductscience.org/library/papers/74566 | PubMed |
| 8 | 603,822 | Lithium salts: therapeutic and unwanted effects. | Br J Hosp Med | 1977 | https://conductscience.org/library/papers/603822 | PubMed |
| 9 | 668,137 | Platelet 5-hydroxytryptamine accumulation in depressive illness. | Clin Chim Acta | 1978 | https://conductscience.org/library/papers/668137 | PubMed |
| 10 | 14,399,272 | A rating scale for depression. | J Neurol Neurosurg Psychiatry | 1960 | https://conductscience.org/library/papers/14399272 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,634,269 | Enzymatic N-Allylation of Primary and Secondary Amines Using Renewable Cinnamic Acids Enabled by Bacterial Reductive Aminases. | ACS Sustain Chem Eng | 2022 | https://conductscience.org/library/papers/35634269 | PubMed |
| 9,295,172 | In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors. | J Neural Transm (Vienna) | 1997 | https://conductscience.org/library/papers/9295172 | PubMed |
| 7,420,073 | Antidepressant drugs and ethanol: behavioral and pharmacokinetic interactions in mice. | J Neural Transm | 1980 | https://conductscience.org/library/papers/7420073 | PubMed |
| 7,002,182 | Measurement of serum drug levels in the assessment of antidepressants. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7002182 | PubMed |
| 6,768,073 | Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6768073 | PubMed |
| 6,457,309 | Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6457309 | PubMed |
| 6,452,151 | Effect of zimelidine, a new antidepressant, on appetite and body weight. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6452151 | PubMed |
| 6,450,427 | Plasma levels of zimelidine and norzimelidine in endogenous depression. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6450427 | PubMed |
| 6,448,650 | Event recording in a clinical trial of a new medicine. | Br Med J | 1980 | https://conductscience.org/library/papers/6448650 | PubMed |
| 6,445,274 | Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6445274 | PubMed |
| 6,438,684 | Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6438684 | PubMed |
| 6,429,698 | Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6429698 | PubMed |
| 6,402,001 | Biological classification of depressive illness. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6402001 | PubMed |
| 6,306,711 | Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity. | Psychopharmacology (Berl) | 1983 | https://conductscience.org/library/papers/6306711 | PubMed |
| 6,238,829 | Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6238829 | PubMed |
| 6,228,368 | Pharmacokinetic study of zimelidine using a new GLC method. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6228368 | PubMed |
| 6,227,367 | Safety of zimeldine in overdose. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6227367 | PubMed |
| 6,226,335 | Possible hepatotoxicity of zimelidine. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6226335 | PubMed |
| 6,215,240 | Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. | Drugs | 1982 | https://conductscience.org/library/papers/6215240 | PubMed |
| 6,215,083 | Severe headache and disturbed liver function during treatment with zimelidine. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6215083 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/113803
GET https://conductscience.org/api/papers/v1/113803/cited_by?page=2